🇺🇸 Phentermine-Topiramate in United States

FDA authorised Phentermine-Topiramate on 17 July 2012

Marketing authorisations

FDA — authorised 17 July 2012

  • Application: NDA022580
  • Marketing authorisation holder: VIVUS LLC
  • Local brand name: QSYMIA
  • Indication: CAPSULE, EXTENDED RELEASE — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Phentermine-Topiramate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Phentermine-Topiramate approved in United States?

Yes. FDA authorised it on 17 July 2012; FDA has authorised it.

Who is the marketing authorisation holder for Phentermine-Topiramate in United States?

VIVUS LLC holds the US marketing authorisation.